Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate Cancer.
Gharzai LA, Jiang R, Jaworski EM, Morales Rivera K, Dess RT, Jackson WC, Hartman HE, Mehra R, Kishan AU, Solanki AA, Schaeffer EM, Feng FY, Zaorsky NG, Berlin A, Ponsky L, Shoag J, Sun Y, Schipper MJ, Garcia J, Spratt DE. Gharzai LA, et al. Among authors: mehra r. NEJM Evid. 2023 Apr;2(4):EVIDoa2200195. doi: 10.1056/EVIDoa2200195. Epub 2023 Mar 27. NEJM Evid. 2023. PMID: 38320030
Autoantibody signatures in prostate cancer.
Wang X, Yu J, Sreekumar A, Varambally S, Shen R, Giacherio D, Mehra R, Montie JE, Pienta KJ, Sanda MG, Kantoff PW, Rubin MA, Wei JT, Ghosh D, Chinnaiyan AM. Wang X, et al. Among authors: mehra r. N Engl J Med. 2005 Sep 22;353(12):1224-35. doi: 10.1056/NEJMoa051931. N Engl J Med. 2005. PMID: 16177248 Free article.
The evolving biology and treatment of prostate cancer.
Taichman RS, Loberg RD, Mehra R, Pienta KJ. Taichman RS, et al. Among authors: mehra r. J Clin Invest. 2007 Sep;117(9):2351-61. doi: 10.1172/JCI31791. J Clin Invest. 2007. PMID: 17786228 Free PMC article.
Integrative analysis of genomic aberrations associated with prostate cancer progression.
Kim JH, Dhanasekaran SM, Mehra R, Tomlins SA, Gu W, Yu J, Kumar-Sinha C, Cao X, Dash A, Wang L, Ghosh D, Shedden K, Montie JE, Rubin MA, Pienta KJ, Shah RB, Chinnaiyan AM. Kim JH, et al. Among authors: mehra r. Cancer Res. 2007 Sep 1;67(17):8229-39. doi: 10.1158/0008-5472.CAN-07-1297. Cancer Res. 2007. PMID: 17804737
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer.
Varambally S, Laxman B, Mehra R, Cao Q, Dhanasekaran SM, Tomlins SA, Granger J, Vellaichamy A, Sreekumar A, Yu J, Gu W, Shen R, Ghosh D, Wright LM, Kladney RD, Kuefer R, Rubin MA, Fimmel CJ, Chinnaiyan AM. Varambally S, et al. Among authors: mehra r. Neoplasia. 2008 Nov;10(11):1285-94. doi: 10.1593/neo.08922. Neoplasia. 2008. PMID: 18953438 Free PMC article.
Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.
Brenner JC, Ateeq B, Li Y, Yocum AK, Cao Q, Asangani IA, Patel S, Wang X, Liang H, Yu J, Palanisamy N, Siddiqui J, Yan W, Cao X, Mehra R, Sabolch A, Basrur V, Lonigro RJ, Yang J, Tomlins SA, Maher CA, Elenitoba-Johnson KS, Hussain M, Navone NM, Pienta KJ, Varambally S, Feng FY, Chinnaiyan AM. Brenner JC, et al. Among authors: mehra r. Cancer Cell. 2011 May 17;19(5):664-78. doi: 10.1016/j.ccr.2011.04.010. Cancer Cell. 2011. PMID: 21575865 Free PMC article.
1,117 results